BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20718757)

  • 1. Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma.
    Johansson E; Komuro A; Iwata C; Hagiwara A; Fuse Y; Watanabe A; Morishita Y; Aburatani H; Funa K; Kano MR; Miyazono K
    Cancer Sci; 2010 Nov; 101(11):2398-403. PubMed ID: 20718757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
    Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
    Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
    Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
    BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.
    Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
    J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.
    Shirai YT; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
    Am J Pathol; 2011 Dec; 179(6):2920-30. PubMed ID: 21996676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
    Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
    Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-β/Smad signaling.
    Li X; Zhang L; Yin X; Gao Z; Zhang H; Liu X; Pan X; Li N; Yu Z
    Toxicol Lett; 2014 Mar; 225(2):208-15. PubMed ID: 24374174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
    Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.
    Craven KE; Gore J; Wilson JL; Korc M
    Oncotarget; 2016 Jan; 7(1):323-41. PubMed ID: 26586478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.
    Gong K; Xing D; Li P; Aksut B; Ambalavanan N; Yang Q; Nozell SE; Oparil S; Chen YF
    Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L899-907. PubMed ID: 21926264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis.
    Pu H; Begemann DE; Kyprianou N
    Endocrinology; 2017 Jun; 158(6):1612-1622. PubMed ID: 28324007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
    Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
    J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.